Luyan Pharma Co.,Ltd. (002788.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap8.23B
Enterprise Value14.58B
P/E Ratio13.79
PEG Ratio-1.1
Price/Sales Ratio0.17
Price/Book Ratio1.11
Enterprise/Revenue0.38
Enterprise/EBITDA12.47

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.01
Operating Margin0.02
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.08

Income Statement

Revenue21.25B
Revenue/Share55.52
Gross Profit1.5B
EBITDA701.31M
Net Income280.88M
Diluted EPS0.72

Balance Sheet

Total Cash450.8M
Total Cash/Share1.16
Total Debt4.97B
Total Debt/Equity1.48
Current Ratio1.12
Book Value Per Share8.66

Price History

52-Week Change-4.93
52-Week High28.29
52-Week Low8.96
Moving Average 50 Days10.43
Moving Average 200 Days12.37

Statistics

Average Volume12.54M
Shares Outstanding388.52M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.35
Trailing Annual Dividend Yield3.63
Payout Ratio1.12
Last Split Factor1073:1000
Last Split DateSeptember 17, 2020
AD